Biomea Fusion Inc.

Last updated September 27, 2026

Organization details

Legal name
Biomea Fusion Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Carlos
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BMEA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001840439

Board of directors

Chief executives

Thomas Andrew Butler · Chief Executive Officer
Dates unknown
Michael J.m. Hitchcock · Interim CEO Interim
Dates unknown

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 5 other boards. 4 are in the same sector.

Network of Biomea Fusion Inc.'s board connections BlossomHill Therapeutics Inc. BlossomHill Therapeuti... BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... BridgeBio Pharma Inc. BridgeBio Pharma Inc. Erasca Inc. Erasca Inc. Helix Acquisition Corp. III Helix Acquisition Corp... Bihua Chen Bihua Chen Eric Aguiar Eric Aguiar Biomea Fusion Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$196,400
4 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −50,600 — —
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift +50,600 — —
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −50,000 — —
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift +50,000 — —
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −50,000 — —
Dec 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift +50,000 — —
Dec 11, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Open-market purchase +30,000 $1.43 $42,900
Dec 2, 2025 Michael J.m. Hitchcock Director, Officer (Interim CEO) Open-market purchase +100,000 $0.99 $99,000
Dec 1, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Open-market purchase +10,000 $1.05 $10,500
Nov 28, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Open-market purchase +40,000 $1.10 $44,000
Jan 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −10,000 — —
Jan 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift +10,000 — —
Jan 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −10,000 — —
Jan 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift +10,000 — —
Jan 31, 2025 Rainer M. Erdtmann Director, Officer (See Remarks) Gift −10,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Biomea Fusion Inc.

Who is the CEO of Biomea Fusion Inc.?

Thomas Andrew Butler is Biomea Fusion Inc.'s Chief Executive Officer.

How many directors are on Biomea Fusion Inc.'s board?

Biomea Fusion Inc.'s board has 8 directors: Bihua Chen, Elizabeth Faust, Eric Aguiar, Julianne Averill, Michael J.m. Hitchcock, Rainer M. Erdtmann, Sumita Ray and Thomas Andrew Butler.

Are Biomea Fusion Inc. insiders buying or selling shares?

Over the last 12 months, Biomea Fusion Inc. insiders bought $196,400 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="biomea-fusion-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.